19 Dec 2022 --- Beiersdorf has acquired a majority stake in Belgian life-science company S-Biomedic, strengthening its portfolio of acne treatments developed through skin microbiome research. S-Biomedic will continue to be managed as a standalone entity under Beiersdorf’s existing microbiome program and will complement the company’s research activities in this field.“Microbiome research is one of the spotlight topics in life science and offers unique starting points for break-through skin care innovations,” a Beiersdorf spokesperson tells PersonalCareInsights.
